Breath is the next frontier of non-invasive screening.

Breath analysis — breathomics / volatolomics — detects cancer, infection, and metabolic disease from exhaled VOCs, aerosols, and microbiomes. This is the open global hub for the breath research community: a searchable database of 305 organizations worldwide, along with technology primers, clinical/regulatory signals, and resources for collaboration.

305
Organizations (global)
83 / 305
Leading / core (L1)
90
High-impact (Lv 4–5)
82
Added Nov 2026 (IABR)

One place for breath researchers worldwide.

Breath analysis spans many technologies — FAIMS, GC-MS, e-nose, MSS, nanoparticle biomarker tagging — and information sources for clinical, regulatory, and IP are fragmented. We structure this landscape along four axes (tech / clinical / business / IP) and place it in the context of international standardization efforts.

Searchable DB of 305 orgs

Filter by layer, technology, disease, region, and prominence. See full profiles with technology details, collaborations, and SWOT. v2 adds GeNose, Menssana, Ancon, Delfi, Nightingale, and 35 more.

Updated: Sep 2026 (v2.3)

Technology primers

FAIMS, GC-MS/GC-IMS, SIFT-MS, PTR-MS, SESI, e-nose (MOS), MSS, NBT, optical (NIR/MIR/QCL), RF/THz. Principles, sensitivity, sampling standards, operational cost.

6 articles · expanding

Clinical, regulatory, paper signals

Monthly highlights from ClinicalTrials.gov, leading journals (J Breath Res, Metabolites, Anal Chem), FDA/EMA/PMDA notices, and major conferences.

Monthly updates

High-prominence, pioneering organizations

Organizations that pioneered research, clinical work, and commercialization in breath analysis. Technology, evidence, and collaborations for each are in the organization database.

Tier 1

Owlstone Medical

UK · FAIMS · Breath Biopsy®

Pioneer of FAIMS-based clinical breath analysis. ReCIVA / ReCIVA Evo sampling platform plus a Clinical LDT pipeline for MCED use cases (lung / liver / pancreas / GI).

Tier 1

Breathomix

NL · e-nose (SpiroNose) · Infection / Resp.

Cloud-based e-nose analytics platform. Built COPD / asthma / COVID / tuberculosis evidence across Europe; CE-IVD cleared.

Tier 1

Nanose Medical / Technion (Haick)

IL · e-nose + nanoparticle · Multi-disease

Technion Haick lab spinout. NA-NOSE sensors and multi-disease VOC pattern recognition (17+ diseases). Foundational publications for the field.

Tier 1 NEW in v2

UGM / GeNose C19

Indonesia · e-nose · COVID / infection

National-scale deployment: millions of breath screenings for COVID-19 during the pandemic. A benchmark for operational design of breath×infection use cases.

Tier 1 NEW in v2

Menssana Research

US · TD-GC-MS · Multi-disease VOC

Decades-long breath VOC research lineage (Michael Phillips). Unique biomarker library and evidence for breast / lung / TB / transplant rejection.

Tier 1

HIROTSU Bio

JP · nematode N-NOSE · Multi-cancer

Urine × nematode-based multi-cancer early detection. Largest consumer + corporate health screening deployment among Japanese players in non-invasive×multi-cancer.